Inhibition of radioligand binding to A1 adenosine receptors by Bay K8644 and nifedipine.

[1]  Syed Jamal Mustafa,et al.  Effect of calcium entry blockers and adenosine on the relaxation of large and small coronary arteries. , 1986, Life sciences.

[2]  J. Hammond,et al.  Affinity of calcium channel inhibitors, benzodiazepines, and other vasoactive compounds for the nucleoside transport system. , 1985, Canadian journal of physiology and pharmacology.

[3]  Chi-Ming Lee,et al.  Inhibitory effect of adenosine on electrically evoked contractions in the rat vas deferens: Pharmacological characterization , 1985, Neuroscience Letters.

[4]  Chi-Ming Lee.  Inhibitory effect of adenosine on electrically evoked contractions in the rat vas deferens: Calcium dependence , 1985, Neuroscience Letters.

[5]  M. Welcome,et al.  Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors. , 1985, Biochemical pharmacology.

[6]  J. Phillis,et al.  Interactions between adenosine and nifedipine in the rat cerebral cortex , 1984, Neurochemistry International.

[7]  J. Patel,et al.  Adenosine uptake sites in dog heart and brain; interaction with calcium antagonists. , 1984, Life sciences.

[8]  P. Bellemann.  Binding properties of a novel calcium channel activating dihydropyridine in monolayer cultures of beating myocytes , 1984, FEBS letters.

[9]  J. Young,et al.  Nucleoside transport. Photoaffinity labelling of high-affinity nitrobenzylthioinosine binding sites in rat and guinea pig lung. , 1984, Biochemical and biophysical research communications.

[10]  K. Hermsmeyer,et al.  Calcium Antagonists and Excitation of the Vascular Muscle Membrane , 1984, Journal of cardiovascular pharmacology.

[11]  G. Merrill,et al.  Comparative effects of adenosine and nifedipine in rabbit vascular smooth muscle. , 1983, Canadian Journal of Physiology and Pharmacology.

[12]  I. Grupp,et al.  Diltiazem potentiates the negative inotropic action of nimodipine in heart. , 1983, Biochemical and biophysical research communications.

[13]  D. J. Triggle,et al.  New developments in calcium ion channel antagonists , 1983 .

[14]  R. Wadsworth,et al.  The effects of calcium channel inhibitors and other procedures affecting calcium translocation on drug‐induced rhythmic contractions in the rat vas deferens , 1983, British journal of pharmacology.

[15]  M. Schramm,et al.  Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels , 1983, Nature.

[16]  G. Merrill,et al.  Coronary interactions between nifedipine and adenosine in the intact dog heart. , 1982, European Journal of Pharmacology.

[17]  J. Daly.  Adenosine receptors: targets for future drugs. , 1982, Journal of medicinal chemistry.

[18]  T. W. Stone.  THE EFFECTS OF 4‐AMINOPYRIDINE ON THE ISOLATED VAS DEFERENS AND ITS EFFECTS ON THE INHIBITORY PROPERTIES OF ADENOSINE, MORPHINE, NORADRENALINE AND γ‐AMINOBUTYRIC ACID , 1981, British journal of pharmacology.

[19]  E. M. Silinsky.  ON THE CALCIUM RECEPTOR THAT MEDIATES DEPOLARIZATION‐SECRETION COUPLING AT CHOLINERGIC MOTOR NERVE TERMINALS , 1981, British journal of pharmacology.

[20]  B B Fredholm,et al.  Modulation of neurotransmission by purine nucleotides and nucleosides. , 1980, Biochemical pharmacology.

[21]  S. Snyder,et al.  [3H]Para-amino-clonidine: A novel ligand which binds with high affinity to α-adrenergic receptors , 1979 .

[22]  T. Stone,et al.  An electrophysiological demonstration of a synergistic interaction between norepinephrine and adenosine in the cerebral cortex , 1978, Brain Research.

[23]  S. Snyder,et al.  3H-Spiroperidol labels dopamine receptors in pituitary and brain. , 1977, European journal of pharmacology.

[24]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.